BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 35337018)

  • 1. Repurposing Probenecid to Inhibit SARS-CoV-2, Influenza Virus, and Respiratory Syncytial Virus (RSV) Replication.
    Tripp RA; Martin DE
    Viruses; 2022 Mar; 14(3):. PubMed ID: 35337018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probenecid Inhibits Respiratory Syncytial Virus (RSV) Replication.
    Murray J; Bergeron HC; Jones LP; Reener ZB; Martin DE; Sancilio FD; Tripp RA
    Viruses; 2022 Apr; 14(5):. PubMed ID: 35632652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thapsigargin Is a Broad-Spectrum Inhibitor of Major Human Respiratory Viruses: Coronavirus, Respiratory Syncytial Virus and Influenza A Virus.
    Al-Beltagi S; Preda CA; Goulding LV; James J; Pu J; Skinner P; Jiang Z; Wang BL; Yang J; Banyard AC; Mellits KH; Gershkovich P; Hayes CJ; Nguyen-Van-Tam J; Brown IH; Liu J; Chang KC
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33546185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triazavirin might be the new hope to fight Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
    Hudecová IMJČGKMPL
    Ceska Slov Farm; 2021; 70(1):18-25. PubMed ID: 34237949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 4'-Fluorouridine is an oral antiviral that blocks respiratory syncytial virus and SARS-CoV-2 replication.
    Sourimant J; Lieber CM; Aggarwal M; Cox RM; Wolf JD; Yoon JJ; Toots M; Ye C; Sticher Z; Kolykhalov AA; Martinez-Sobrido L; Bluemling GR; Natchus MG; Painter GR; Plemper RK
    Science; 2022 Jan; 375(6577):161-167. PubMed ID: 34855509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Three Multiplex Real-time Reverse Transcription PCR Assays for Simultaneous Detection of SARS-CoV-2, Influenza A/B, and Respiratory Syncytial Virus in Nasopharyngeal Swabs.
    Yun J; Park JH; Kim N; Roh EY; Shin S; Yoon JH; Kim TS; Park H
    J Korean Med Sci; 2021 Dec; 36(48):e328. PubMed ID: 34904407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral Potential of Azelastine against Major Respiratory Viruses.
    Fischhuber K; Bánki Z; Kimpel J; Kragl N; Rössler A; Bolze A; Muellauer B; Angerer J; Nagy G; Nagy E; Szijarto V
    Viruses; 2023 Nov; 15(12):. PubMed ID: 38140540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Respiratory viral infections : Under special consideration of severe acute respiratory syndrome coronavirus 2 and influenza viruses].
    Trauth J
    Med Klin Intensivmed Notfmed; 2023 Sep; 118(6):445-453. PubMed ID: 37642653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recovery from Triple Infection with SARS-CoV-2, RSV and Influenza virus: A case report.
    Guido G; Lalle E; Mosti S; Mencarini P; Lapa D; Libertone R; Ianniello S; Ricciuto GM; Vaia F; Maggi F; Palmieri F
    J Infect Public Health; 2023 Jul; 16(7):1045-1047. PubMed ID: 37196367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial co-infections in community-acquired pneumonia caused by SARS-CoV-2, influenza virus and respiratory syncytial virus.
    Hedberg P; Johansson N; Ternhag A; Abdel-Halim L; Hedlund J; Nauclér P
    BMC Infect Dis; 2022 Jan; 22(1):108. PubMed ID: 35100984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influenza A(H1N1)pdm09 Virus but Not Respiratory Syncytial Virus Interferes with SARS-CoV-2 Replication during Sequential Infections in Human Nasal Epithelial Cells.
    Fage C; Hénaut M; Carbonneau J; Piret J; Boivin G
    Viruses; 2022 Feb; 14(2):. PubMed ID: 35215988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influenza A and Respiratory Syncytial Virus Trigger a Cellular Response That Blocks Severe Acute Respiratory Syndrome Virus 2 Infection in the Respiratory Tract.
    Dee K; Schultz V; Haney J; Bissett LA; Magill C; Murcia PR
    J Infect Dis; 2023 Jun; 227(12):1396-1406. PubMed ID: 36550077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between the Viral Illness Caused by SARS-CoV-2, Influenza Virus, Respiratory Syncytial Virus and Other Respiratory Viruses in Pediatrics.
    Brigadoi G; Demarin GC; Boracchini R; Pierantoni L; Rossin S; Barbieri E; Tirelli F; Cantarutti A; Tempo G; Giaquinto C; Lanari M; Da Dalt L; Donà D
    Viruses; 2024 Jan; 16(2):. PubMed ID: 38399975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Verdinexor Targeting of CRM1 is a Promising Therapeutic Approach against RSV and Influenza Viruses.
    Pickens JA; Tripp RA
    Viruses; 2018 Jan; 10(1):. PubMed ID: 29361733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Burden of Influenza and Respiratory Syncytial Viruses in Suspected COVID-19 Patients: A Cross-Sectional and Meta-Analysis Study.
    Costa VGD; Gomes AJC; Bittar C; Geraldini DB; Previdelli da Conceição PJ; Cabral ÁS; Carvalho T; Biselli JM; Provazzi PJS; Campos GRF; Sanches PRDS; Costa PI; Nogueira ML; Araujo JP; Spilki FR; Calmon MF; Rahal P
    Viruses; 2023 Mar; 15(3):. PubMed ID: 36992374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-chlorotaurine is highly active against respiratory viruses including SARS-CoV-2 (COVID-19)
    Lackner M; Rössler A; Volland A; Stadtmüller MN; Müllauer B; Banki Z; Ströhle J; Luttick A; Fenner J; Sarg B; Kremser L; Tone P; Stoiber H; von Laer D; Wolff T; Schwarz C; Nagl M
    Emerg Microbes Infect; 2022 Dec; 11(1):1293-1307. PubMed ID: 35418279
    [No Abstract]   [Full Text] [Related]  

  • 17. Repurposing of antiparasitic niclosamide to inhibit respiratory syncytial virus (RSV) replication.
    Niyomdecha N; Suptawiwat O; Boonarkart C; Thitithanyanont A; Auewarakul P
    Virus Res; 2021 Apr; 295():198277. PubMed ID: 33476693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical phenotypes and outcomes of SARS-CoV-2, influenza, RSV and seven other respiratory viruses: a retrospective study using complete hospital data.
    Hedberg P; Karlsson Valik J; van der Werff S; Tanushi H; Requena Mendez A; Granath F; Bell M; Mårtensson J; Dyrdak R; Hertting O; Färnert A; Ternhag A; Naucler P
    Thorax; 2022 Feb; 77(2):154-163. PubMed ID: 34226206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High prevalence of SARS-CoV-2 and influenza A virus (H1N1) coinfection in dead patients in Northeastern Iran.
    Hashemi SA; Safamanesh S; Ghasemzadeh-Moghaddam H; Ghafouri M; Azimian A
    J Med Virol; 2021 Feb; 93(2):1008-1012. PubMed ID: 32720703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transmission of paediatric respiratory syncytial virus and influenza in the wake of the COVID-19 pandemic.
    Williams TC; Sinha I; Barr IG; Zambon M
    Euro Surveill; 2021 Jul; 26(29):. PubMed ID: 34296673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.